States must invest in Health

*By Joanna Kozakou States are under unprecedented pressure to achieve the correct balance between universal access to high quality Health services and adhering to budgetary constraints. As the European Union’s Commissioner for Health and Consumer Policy, Tonio Borg,...

Invest in health and medicinal innovation

*By Petros Mavrogenis We have recently been observing the difficulties and challenges faced by many European states. Cutting costs is imperative. Today, more than ever, we must not view costs as mere expenditures but more as an investment, which will bring long term...

What really is involved in developing a new drug?

Did you know that it takes on average 12 years for a new medicine to get from the lab to the shelves of your Pharmacy? Did you know that only 5 in every 5.000 compounds that enter the preclinical testing phase actually make it to human testing? Did you know that only...